|
|
|
|
|
|
|
|
|
CO-ADMINISTRATION MAY BE ASSOCIATED WITH INCREASED RISK OF BLEEDING
|
SALICYLATES ENHANCE ACTIVITY OF THE DRUG
|
SALICYLATES ENHANCE ACTIVITY OF THE DRUG
|
SALICYLATES ENHANCE ACTIVITY OF THE DRUG
|
SALICYLATES ENHANCE ACTIVITY OF THE DRUG
|
SALICYLATES ENHANCE ACTIVITY OF THE DRUG
|
SALICYLATES ENHANCE ACTIVITY OF THE DRUG
|
SALICYLATES ENHANCE ACTIVITY OF THE DRUG
|
SALICYLATES ENHANCE ACTIVITY OF THE DRUG
|
SALICYLATES ENHANCE ACTIVITY OF THE DRUG
|
SALICYLATES ENHANCE ACTIVITY OF THE DRUG
|
SALICYLATES ENHANCE ACTIVITY OF THE DRUG
|
CO-ADMINISTRATION HAS RESULTED IN BLEEDING AND/OR INCREASED PROTHROMBIN TIME IN FEW PATIENTS
|
CO-ADMINISTRATION HAS RESULTED IN BLEEDING AND/OR INCREASED PROTHROMBIN TIME IN FEW PATIENTS
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS ; THESE EFFECTS MAY BE PRONOUNCED IN THE ELDERLY
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS ; THESE EFFECTS MAY BE PRONOUNCED IN THE ELDERLY
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS ; THESE EFFECTS MAY BE PRONOUNCED IN THE ELDERLY
|
MUCOPOLYSACCHARIDE POLYSULFATE IS INCOMPATIBLE WITH AMINOGLYCOSIDES
|
MUCOPOLYSACCHARIDE POLYSULFATE IS INCOMPATIBLE WITH AMINOGLYCOSIDES
|
MUCOPOLYSACCHARIDE POLYSULFATE IS INCOMPATIBLE WITH AMINOGLYCOSIDES
|
MUCOPOLYSACCHARIDE POLYSULFATE IS INCOMPATIBLE WITH AMINOGLYCOSIDES
|
MUCOPOLYSACCHARIDE POLYSULFATE IS INCOMPATIBLE WITH AMINOGLYCOSIDES
|
MUCOPOLYSACCHARIDE POLYSULFATE IS INCOMPATIBLE WITH AMINOGLYCOSIDES
|
MUCOPOLYSACCHARIDE POLYSULFATE IS INCOMPATIBLE WITH AMINOGLYCOSIDES
|
MUCOPOLYSACCHARIDE POLYSULFATE IS INCOMPATIBLE WITH AMINOGLYCOSIDES
|